VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +4.5% ·
Aktienfluss -0.5% ·
neue Nettopositionen +4.3%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 173 | -1 | 210.42M | $104.38B | +5 | −7 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.73M | +0.7% | $12.79B | 1.9% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passiv) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 3 | BlackRock ✦ (passiv) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ ×22 |
| 4 | State Street Global Advisors ✦ (passiv) | 11.78M | -0.1% | $5.24B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 6 | Geode Capital Management ✦ (passiv) | 5.93M | +2.9% | $2.63B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ ×8 |
| 8 | Norges Bank ✦ (passiv) | 3.58M | +6.4% | $1.59B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.16M | +8.3% | $1.41B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 1.00M | -14.2% | $447.38M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 212.48K | +58.0% | $94.60M | 0.1% | ▲ Add | 5 | SEC ↗ ×4 |
| 12 | Adage Capital Partners ✦ | 178.19K | -63.6% | $79.33M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 141.54K | -3.0% | $62.23M | 0.1% | ▼ Trim | 5 | SEC ↗ ×4 |
| 14 | Marshall Wace ✦ | 117.00K | -15.2% | $52.09M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 61.47K | Neu | $27.37M | 0.0% | New | 1 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 37.25K | -2.8% | $16.59M | 1.5% | ▼ Trim | 5 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 34.39K | Neu | $15.31M | 0.1% | New | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 28.83K | +474.4% | $12.83M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 19 | Fisher Asset Management ✦ | 25.75K | -16.0% | $11.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | ARK Investment Management ✦ | 24.06K | -8.7% | $10.71M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 21.36K | -23.1% | $9.51M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 20.08K | -72.1% | $8.94M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 23 | GAMCO Investors ✦ | 512 | Neu | $227,942 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Arrowstreet Capital | $27.37M | 0.0% |
| Bridgewater Associates | $15.31M | 0.1% |
| GAMCO Investors | $227,942 | 0.0% |
Ausgestiegen
| Millennium Management | $150.26M | war 0.2% |
| Two Sigma Investments | $2.00M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1,678 Inhaber, 225.07M Anteile, $98.10B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.